Showing 3 of 3 recruiting trials for “transitional-cell-carcinoma-of-the-corpus-uteri”
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma
👨⚕️ Clare Scott, AM MB BS PhD, Peter MacCallum Cancer Centre, Australia📍 6 sites📅 Started May 2023View details ↗
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →